Arine completed $30 million Series C Round funding
Sector:
AI
Software
Digital Health
06/24/2025
San Francisco, CA USA
Arine
completed $30 million Series C Round funding. Investors include
Town Hall Ventures (lead), Kaiser Permanente Ventures.
"This is a defining moment for healthcare and for Arine," said Yoona Kim, PharmD, PhD, CEO and co-founder of Arine. "Mounting cost pressures and sweeping policy changes are forcing the industry to rethink how care is delivered. Amid these challenges, medications have emerged as one of the most powerful—and underleveraged—tools to improve outcomes and control costs. With this new capital, we're expanding our ability to deliver meaningful impact for each patient, when the system needs it most."
About
Arine is a leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and at-risk provider organizations to enhance medication safety, adherence, and effectiveness among their members.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
